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Chromatin remodelling plays important roles in gene regulation during 7 
development, differentiation and in disease. The chromatin remodelling 8 
enzyme CHD4 is a component of the NuRD and ChAHP complexes that are 9 
involved in gene repression. Here we report the cryo-electron microscopy 10 
(cryo-EM) structure of Homo sapiens CHD4 engaged with a nucleosome 11 
core particle in the presence of the non-hydrolysable ATP analogue AMP-12 
PNP at an overall resolution of 3.1 Å. The ATPase motor of CHD4 binds and 13 
distorts nucleosomal DNA at superhelical location (SHL) +2, supporting the 14 
‘twist defect’ model of chromatin remodelling. CHD4 does not induce 15 
unwrapping of terminal DNA, in contrast to its homologue Chd1, which 16 
functions in gene activation. Our structure also maps CHD4 mutations that 17 
are associated with human cancer or the intellectual disability disorder 18 
Sifrim-Hitz-Weiss syndrome. 19 
In the nucleus of eukaryotic cells, DNA is compacted into chromatin. The 20 
fundamental building block of chromatin is the nucleosome, a complex of ~146 21 
base pairs (bp) of DNA wrapped around an octamer of histone proteins. The 22 
degree of chromatin compaction influences DNA replication, transcription, and 23 
repair. Maintenance of the appropriate chromatin state requires ATP-dependent 24 
chromatin-remodelling enzymes. These ‘chromatin remodellers’ are divided into 25 
four families called CHD, SWI/SNF, ISWI, and INO80 (Clapier et al., 2017). All 26 
chromatin remodellers contain a conserved ATPase core that hydrolyses ATP to 27 
alter contacts between nucleosomal DNA and the histone octamer and to 28 
facilitate nucleosome assembly, sliding, ejection, or histone exchange. 29 
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Members of the CHD (‘chromodomain helicase DNA-binding’) family of 30 
chromatin remodellers all contain a central SNF2-like ATPase motor domain and 31 
a double chromodomain in their N-terminal region. The double chromodomain 32 
binds modified histones (Sims et al., 2005) and interacts with nucleosomal DNA 33 
to regulate ATPase activity (Nodelman et al., 2017). Recent structures of the 34 
yeast remodeller Chd1 in complex with a nucleosome uncovered the architecture 35 
of one subfamily of CHD remodellers (subfamily I) and its interactions with the 36 
nucleosome (Farnung et al., 2017; Sundaramoorthy et al., 2018). A unique 37 
feature of these structures is that Chd1 binding induces unwrapping of terminal 38 
DNA from the histone octamer surface at superhelical location (SHL) -6 and -7 39 
(Farnung et al., 2017; Sundaramoorthy et al., 2018). However, the resolution of 40 
these studies was limited, such that atomic details were not resolved. 41 
The human CHD family member CHD4 (Woodage et al., 1997) shows 42 
nucleosome spacing activity (Silva et al., 2016). CHD4 is also known as Mi-2 in 43 
D. melanogaster (Kehle et al., 1998). CHD4, CHD3, and CHD5 form CHD 44 
subfamily II, which differs in domain architecture from subfamily I. CHD3, CHD4, 45 
and CHD5 contain two N-terminal plant homeodomain (PHD) zinc finger domains 46 
(Schindler et al., 1993), a DNA-interacting double chromodomain, and the 47 
ATPase motor. CHD4 contains an additional high mobility group (HMG) box-like 48 
domain in its N-terminal region(Silva et al., 2016) and two additional domains of 49 
unknown function that are located in the C-terminal region.  50 
CHD4 is implicated in the repression of lineage-specific genes during 51 
differentiation (Liang et al., 2017) and is required for the establishment and 52 
maintenance of more compacted chromatin structures (Bornelöv et al., 2018). 53 
CHD4 mutations have a high incidence in some carcinomas (Getz et al., 2013) 54 
and in thyroid and ovarian cancers (Längst and Manelyte, 2015). Mutations in 55 
CHD4 have also been implicated in intellectual disability syndromes (Sifrim et al., 56 
2016; Weiss et al., 2016). 57 
CHD4 is a subunit of the multi-subunit Nucleosome Remodelling 58 
Deacetylase (NuRD) complex (Tong et al., 1998; Xue et al., 1998; Zhang et al., 59 
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1998). NuRD also contains the deacetylase HDAC1/2 and accessory subunits 60 
that serve regulatory and scaffolding roles. NuRD is implicated in gene silencing, 61 
but also gene activation (Gnanapragasam et al., 2011). It is essential for cell 62 
cycle progression (Polo et al., 2010), DNA damage response (Larsen et al., 63 
2010; Smeenk et al., 2010), establishment of heterochromatin (Sims and Wade, 64 
2011), and differentiation (Bornelöv et al., 2018; Burgold et al., 2019). In addition, 65 
CHD4 is part of the heterotrimeric ChAHP complex that is also involved in gene 66 
repression (Ostapcuk et al., 2018). 67 
Thus far, structural studies of CHD4 have been limited to individual 68 
domains (Kwan et al., 2003; Mansfield et al., 2011). Here we report the cryo-69 
electron microscopy (cryo-EM) structure of human CHD4 bound to a nucleosome 70 
at an overall resolution of 3.1 Å. CHD4 engages the nucleosome at SHL +2 and 71 
induces a conformational change in DNA at this location in the presence of the 72 
ATP analogue adenylyl imidodiphosphate (AMP-PNP). Structural comparisons 73 
show that CHD4, in contrast to Chd1, does not induce unwrapping of terminal 74 
DNA, and this is also observed in biochemical assays. Maintenance of the 75 
integrity of the nucleosome in the presence of CHD4 is consistent with the role of 76 
CHD4 in gene repression, and in heterochromatin formation and maintenance. 77 
Finally, the detailed nucleosome-CHD4 structure enables mapping of known 78 
human disease mutations (Kovač et al., 2018; Sifrim et al., 2016; Weiss et al., 79 




Nucleosome-CHD4 complex structure 84 
To investigate how the human chromatin remodeller CHD4 engages a 85 
nucleosome, we determined the structure of H. sapiens CHD4 bound to a 86 
Xenopus laevis nucleosome core particle in the presence of the ATP analogue 87 
AMP-PNP. We recombinantly expressed and purified full-length CHD4 and 88 
reconstituted a complex of CHD4 with a pre-assembled nucleosome core 89 
Page 4 of 32 
particle. The nucleosome comprised 145 base pairs (bp) of DNA, corresponding 90 
to the Widom 601 sequence (Lowary and Widom, 1998) with additional 4 and 30 91 
bp of extranucleosomal DNA on the entry and exit side of the nucleosome, 92 
respectively. The nucleosome-CHD4 complex was purified by size exclusion 93 
chromatography (Figure 1-figure supplement 1). 94 
To determine the structure of the nucleosome-CHD4 complex, we 95 
collected single particle cryo-EM data on a Titan Krios (FEI) microscope 96 
equipped with a K2 direct electron detector (Gatan) (Methods). We obtained a 97 
cryo-EM reconstruction of the nucleosome-CHD4 complex at an overall 98 
resolution of 3.1 Å (FSC 0.143 criterion) (Figure 1-figure supplement 2-4, Video 99 
1). The nucleosome was resolved at a resolution of 3.0-4.5 Å, whereas CHD4 100 
was resolved at 3.1-5.0 Å, depending on the protein region. The register of the 101 
DNA was unambiguously determined based on distinct densities for purine and 102 
pyrimidine nucleotides around the dyad (Figure 1-figure supplement 3h). Well-103 
defined density was also obtained for AMP-PNP and a coordinated magnesium 104 
ion in the CHD4 active site (Figure 1-figure supplement 3i). The model was 105 
locally adjusted and real-space refined, leading to very good stereochemistry 106 
(Methods) (Table 1).  107 
 108 
CHD4 architecture 109 
The CHD4 ATPase motor binds the nucleosome at SHL +2 (Figure 1, Figure 1-110 
figure supplement 4f). Binding at this location has also been observed for the 111 
chromatin remodellers Chd1 (Farnung et al., 2017; Sundaramoorthy et al., 2018), 112 
Snf2 (Liu et al., 2017), and Swr1 (Willhoft et al., 2018). The ATPase motor is in a 113 
closed, post-translocated state with AMP-PNP bound in the active site. The same 114 
state and a similar conformation was observed for Chd1 when bound to 115 
ADP·BeF3 (Farnung et al., 2017; Sundaramoorthy et al., 2018, 2017). The double 116 
chromodomain is located at SHL +1 and contacts the nucleosomal DNA 117 
phosphate backbone via electrostatic interactions, in a fashion similar to that 118 
observed for S. cerevisiae Chd1 (Figure 1) (Farnung et al., 2017; Nodelman et 119 
al., 2017).  120 
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The PHD finger 2 of CHD4 is located near SHL +0.5 and the double 121 
chromodomain. This is consistent with NMR studies that predicted binding of this 122 
PHD finger close to the dyad axis and the H3 tail (Gatchalian et al., 2017). 123 
Additionally, we observe parts of the C-terminal bridge (Hauk et al., 2010), an 124 
amino acid segment that follows the ATPase lobe. Part of the C-terminal bridge 125 
docks against ATPase lobe 2 and extends towards the first ATPase lobe (Figure 126 
1, Figure 1-figure supplement 3j). This region was not resolved in the 127 
nucleosome-Chd1 structures but was observed in a previously published crystal 128 
structure of auto-inhibited Chd1 (Hauk et al., 2010). Taken together, CHD4 and 129 
Chd1 share a core architecture that involves the ATPase motor and the double 130 
chromodomain but differ in their peripheral subfamily-specific protein features. 131 
 132 
CHD4 does not detach exit side nucleosomal DNA 133 
In contrast to the nucleosome-Chd1 structure (Farnung et al., 2017), we did not 134 
observe unwrapping of nucleosomal DNA from the histone octamer on the 135 
second DNA gyre at SHL -6 and -7 (Figure 2a). To test whether this structural 136 
difference can be recapitulated biochemically in solution, we used a Förster 137 
Resonance Energy Transfer (FRET) assay to monitor putative DNA unwrapping 138 
activity by these two chromatin remodellers. The DNA 5’ ends of the nucleosome 139 
were labelled with Cy3 or Cy5 (Figure 2b). Using the doubly labelled 140 
nucleosome, FRET efficiencies were measured in the absence and presence of 141 
S. cerevisiae Chd1 (residues 1-1247) or full-length H. sapiens CHD4, and in the 142 
presence of AMP-PNP or ADP·BeF3.  143 
In these assays, Chd1 showed an increase in fluorescence emission of 144 
the donor and a reduction in the acceptor emission (Figure 2c). This indicated 145 
that the distance between the two DNA ends of the nucleosome increased upon 146 
Chd1 addition, and was consistent with the structurally observed DNA 147 
unwrapping of terminal DNA. In contrast, fluorescence emissions measured for 148 
the CHD4 sample did not differ from the nucleosome controls (Figure 2c), 149 
showing that CHD4 was unable to unwrap nucleosomal DNA both in the 150 
presence of AMP-PNP or ADP·BeF3.  151 
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The major difference in DNA unwrapping between these two remodellers 152 
may be due to a lack of a DNA-binding region in CHD4, when compared to Chd1. 153 
Chd1 uses its DNA-binding region to interact extensively with terminal DNA on 154 
the exit side at SHL -7, and such contacts are absent in the nucleosome-CHD4 155 
structure (Figure 2). It is likely that other CHD family members from subfamily II 156 
such as CHD3 and CHD5, which also lack a DNA-binding region, will also not 157 
induce unwrapping of terminal DNA.  158 
 159 
CHD4-DNA interactions 160 
The high resolution of our nucleosome-CHD4 structure enables a detailed 161 
description of the interactions of the ATPase motor with nucleosomal DNA. 162 
CHD4 contacts the phosphate backbone of the tracking and guide strands via 163 
electrostatic interactions that are mediated by lysine and arginine residues 164 
(Figure 3). These interactions with the DNA phosphate backbone are formed by 165 
residues in the canonical ATPase motifs Ia, Ic, II, IV, IVa, V, and Va and by 166 
residues present in non-canonical motifs (e.g. Lys810) (Figure 3, Figure 3-figure 167 
supplement 1).  168 
We also observe that residues Asn1010, Arg1127, and Trp1148 insert into 169 
the DNA minor groove over a stretch of seven base pairs (Figure 3c). Asn1010 is 170 
not part of a canonical ATPase motif and inserts into the DNA minor groove 171 
around SHL +2.5. Arg1127 (motif V) is universally conserved in all CHD 172 
chromatin remodellers and inserts into the DNA minor groove at SHL +2. Our 173 
density is consistent with two alternative conformations of the Arg1127 side 174 
chain, with the guanidinium head group pointing either towards the tracking or the 175 
guide strand of DNA. Trp1148 is located in motif Va, inserts into the minor groove 176 
near the guide strand, and plays a critical role in coupling ATPase hydrolysis and 177 
DNA translocation (Liu et al., 2017). We further observe a contact between a 178 
negatively charged loop in ATPase lobe 1 (residues 832-837) and the second 179 
DNA gyre at SHL -6. This loop is present in CHD3, CHD4, and CHD5, but not in 180 
Snf2 or ISWI remodellers (Figure 3-figure supplement 1). 181 
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 182 
CHD4 binding distorts DNA at SHL +2 183 
Comparison of our structure with a high-resolution X-ray structure of the free 184 
nucleosome (Vasudevan et al., 2010) reveals a conformational change in the 185 
DNA where the ATPase motor engages its DNA substrate (SHL +2) (Figure 3d). 186 
The high resolution of the nucleosome-CHD4 structure shows that ~5 DNA base 187 
pairs between SHL +1.5 and SHL +2.5 are pulled away from the octamer surface 188 
by up to 3 Å. This distortion does not include the previously observed ‘bulging’ or 189 
a ‘twist defect’ that is characterized by a 1 bp local underwinding of the DNA 190 
duplex and observed when the ATPase motor adopts the open/apo or ADP-191 
bound states (Li et al., 2019). In contrast, the DNA distortion observed in our 192 
AMP-PNP bound state is an intermediate between the bulged and the canonical 193 
DNA conformation (Figure 3d). Such an AMP-PNP bound intermediate DNA 194 
state was predicted based on biochemical experiments (Winger et al., 2018). 195 
This observation demonstrates that the extent of DNA distortion at SHL +2 196 
depends on the functional state of the ATPase motor and is consistent with the 197 
proposed twist defect propagation model of chromatin remodelling (Winger et al., 198 
2018). 199 
 200 
CHD4 binds the histone H4 tail 201 
As observed for S. cerevisiae Chd1 (Farnung et al., 2017), H. sapiens CHD4 202 
contacts the histone H4 tail with its ATPase lobe 2. The H4 tail is located 203 
between ATPase lobe 2 and the nucleosomal DNA at SHL +1.5. The 204 
conformation of the H4 tail differs from that observed in structures of the free 205 
nucleosome where the tail makes inter-nucleosomal contacts with the ‘acidic 206 
patch’ of a neighbouring nucleosome. It also differs from the H4 position 207 
observed in a higher-order structure where the H4 tail extends over the DNA 208 
interface between two nucleosomes (Schalch et al., 2005). A loop in lobe 2 of the 209 
ATPase (CHD4 residues 1001-1006) replaces the H4 tail in this position, 210 
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apparently inducing H4 positioning that allows ATPase lobe 2 binding (Figure 211 
4a). 212 
ATPase lobe 2 contains a highly acidic cavity formed by Asp1080, 213 
Glu1083, Asp1084, and Glu1087 (Figure 4a). This acidic cavity is conserved 214 
across all CHD family members. The basic side chain of the H4 histone tail 215 
residue Arg17 inserts into this acidic cavity (Figure 4a). Similar interactions with 216 
the H4 tail have also been reported for Snf2 and ISWI remodellers (Armache et 217 
al., 2019; Yan et al., 2019). The side chain of H4 Lys16 also points towards the 218 
acidic cavity and is positioned in close proximity to residues Asp1080 and 219 
Glu1083. Acetylation of H4 Lys16 is therefore predicted to weaken these charge-220 
based interactions and to reduce the affinity of chromatin remodellers for the H4 221 
tail. This was noted before (Yan et al., 2016) and is consistent with CDH4 activity 222 
in repressed regions that lack such H4 acetylation. 223 
 224 
CHD4 interacts with histone H3 225 
The ATPase lobe 2 also contacts the core of histone H3 (alpha helix 1, Gln76 226 
and Arg83) via CHD4 residues Asn1004 and Leu1009, respectively (Figure 4b). 227 
This contact is critical for chromatin remodelling. Deletion of the homologous 228 
region in Chd1 leads to abolishment of chromatin remodelling activity 229 
(Sundaramoorthy et al., 2018). However, it remains unclear if these contacts are 230 
required for proper substrate recognition and positioning or whether they are also 231 
necessary to generate the force required for DNA translocation. Low-pass 232 
filtering of our map further shows the H3 N-terminal tail trajectory, which extends 233 
to the double chromodomain (Figure 4c). The contact between the H3 tail and the 234 
double chromodomain could target CHD4 to nucleosomes methylated at Lys27 of 235 
H3 (Kuzmichev et al., 2002), a classical mark for gene repression. 236 
 237 
Two CHD4 molecules can engage with the nucleosome 238 
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During 3D classification of our cryo-EM dataset we observed a distinct class of 239 
particles that showed two CHD4 molecules bound to the same nucleosome 240 
(Figure 5, Figure 1-figure supplement 2-4, Video 2). Refinement of this class of 241 
particles yielded a reconstruction at an overall resolution of 4.0 Å (FSC 0.143 242 
criterion) (Table 1). A model of this nucleosome-CHD42 complex was obtained by 243 
docking the refined nucleosome-CHD4 model into the density and then placing 244 
another CHD4 molecule into the additional density observed on the opposite 245 
side. The resulting nucleosome-CHD42 complex structure shows pseudo-twofold 246 
symmetry with CHD4 molecules bound at SHL +2 and SHL -2 (Figure 5). The 247 
second CHD4 molecule uses its double chromodomain and PHD finger 2 to 248 
contact nucleosomal DNA at SHL +1 and +0.5, respectively. Binding of the 249 
second CHD4 molecule also did not lead to unwrapping of terminal DNA.  250 
Binding of two chromatin remodellers to a single nucleosome was 251 
previously observed for S. cerevisiae Chd1 (Sundaramoorthy et al., 2018) and H. 252 
sapiens SNF2H (Armache et al., 2019). However, in contrast to the structure of 253 
the nucleosome-SNF2H2 complex, we do not observe a distortion in the histone 254 
octamer due to the presence of the chromatin remodellers. Binding of two 255 
remodeller molecules could allow for higher efficiency in positioning the 256 
nucleosome at a precise location but necessitates coordination of the 257 
remodellers. A possible mechanism for coordination could be that twist defects 258 
that are introduced by remodeller binding are propagated from the entry SHL 2 259 
into the exit side SHL 2 (Brandani et al., 2018; Brandani and Takada, 2018). 260 
Presence of the twist defect at the second remodeller binding site could interfere 261 
with the translocation activity of the second remodeller (Sabantsev et al., 2019). 262 
 263 
Cancer-related CHD4 mutations 264 
Many studies have reported mutations in CHD4 that are related to human 265 
diseases, in particular cancer (Xia et al., 2017). Mutations involved in various 266 
cancer phenotypes have been observed in the PHD finger 2, the double 267 
chromodomain, and both lobes of the ATPase motor. To elucidate effects of such 268 
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mutations on CHD4 activity, the Drosophila melanogaster CHD4 homologue Mi-2 269 
has been used as a model protein for functional analysis (Kovač et al., 2018). 270 
CHD4 mutations have been found to fall in two categories. Whereas some 271 
mutations influence ATPase and DNA translocation activity (Arg1162, His1196, 272 
His1151 and Leu1215), other mutations seem to change protein stability 273 
(Leu912, and Cys464) or disrupt DNA binding (Val558 and Arg572). 274 
To try and rationalize these findings, we mapped known CHD4 mutations 275 
on our high-resolution structure (Figure 6, Table 2). Selected sites of mutation 276 
are described below. Mutation of residue His1151 to arginine results in a 277 
significant reduction of ATPase activity and abolishes chromatin remodelling 278 
activity (Kovač et al., 2018). The close proximity of this residue to motif Va 279 
(CHD4 residues 1147-1150) makes it likely that the mutation disrupts motif Va 280 
function, leading to an uncoupling of the ATPase activity from chromatin 281 
remodelling. Similar findings were made for Snf2 where mutation of the 282 
tryptophan residue in motif Va resulted in an uncoupling phenotype (Liu et al., 283 
2017). The most frequently mutated residue in endometrial cancer, arginine 284 
1162, is located in the ATPase motif VI. It forms an ‘arginine finger’ that directly 285 
interacts with AMP-PNP in our structure. Consistent with this observation, 286 
mutation of Arg1162 to glutamine impairs ATP hydrolysis in biochemical assays 287 
(Kovač et al., 2018). 288 
 289 
Other disease-related CHD4 mutations 290 
De novo missense mutations in CHD4 are also associated with an intellectual 291 
disability syndrome with distinctive dysmorphisms (Sifrim et al., 2016; Weiss et 292 
al., 2016). Mutations observed in patients with this syndrome are located in PHD 293 
finger 2 (Cys467Tyr) and predominantly in ATPase lobe 2 (Ser851Tyr, 294 
Gly1003Asp, Arg1068His, Arg1127Gln, Trp1148Leu, Arg1173Leu, and 295 
Val1608Ile). We mapped the sites of these mutations onto our structure (Figure 296 
6) and attempted to predict the effects of the mutations as far as possible (Table 297 
2).  298 
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The Cys467Tyr mutation disrupts coordination of a zinc ion in PHD finger 299 
2. Gly1003 in ATPase lobe2 is located in a loop near H3 alpha helix 1. Deletion 300 
of this loop in Chd1 results in a loss of chromatin remodelling activity 301 
(Sundaramoorthy et al., 2018). Residue Arg1068 forms a hydrogen bond network 302 
with the side chain of Thr1137 and the main chain carbonyl groups of Phe1112 303 
and Gln1119. The Arg1068Cys mutation disrupts this network and is predicted to 304 
impair the integrity of the ATPase fold. Mutation of Arg1127 disrupts its 305 
interactions with the DNA minor groove (Figure 2c). The equivalent arginine 306 
residue in SMARCA4, which is one of the catalytic subunits of the BAF complex, 307 
has been implicated in the rare genetic disorder Coffin-Siris syndrome (Tsurusaki 308 
et al., 2012). Trp1148, which is part of ATPase motif Va, contacts the guide 309 
strand in a fashion similar to Chd1 and Snf2 (Farnung et al., 2017; Liu et al., 310 
2017) (Figure 2c). Mutation of this residue uncouples ATP hydrolysis and 311 
chromatin remodelling (Liu et al., 2017). Arg1173 inserts into an acidic pocket 312 
formed by residues Glu971, Asp1147, and Asp1153. Mutation of the arginine 313 
residue to leucine is likely to destabilize ATPase lobe 2 folding. 314 
 315 
Discussion 316 
Here we provide the 3.1 Å resolution cryo-EM structure of human CHD4 engaged 317 
with a nucleosome and the 4.0 Å resolution structure of a nucleosome-CHD42 318 
complex that contains two molecules of CHD4. Our structure of the nucleosome-319 
CHD4 complex reveals how a subfamily II CHD remodeller engages with its 320 
nucleosomal substrate. We observe a distortion of nucleosomal DNA at SHL +2 321 
in the presence of AMP-PNP. Similar observations were previously made for the 322 
Snf2 chromatin remodeller (Li et al., 2019; Liu et al., 2017) in its apo and ADP-323 
bound states.  324 
Our high-resolution structure fills a gap in our understanding of the 325 
mechanism of chromatin remodelling by capturing an additional enzymatic state. 326 
The DNA distortion at SHL +2 that we observed in the AMP-PNP bound state 327 
differs from distortions observed previously in the apo and ADP bound state that 328 
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involved a twist distortion (Li et al., 2019; Winger et al., 2018). This is consistent 329 
with a proposed ‘twist defect’ mechanism for chromatin remodelling (Li et al., 330 
2019; Sabantsev et al., 2019). In this model, binding of the ATPase motor at SHL 331 
±2 induces a twist defect in the DNA. Subsequent ATP binding, captured by 332 
AMP-PNP and ADP·BeF3 structures, then leads to closing of the ATPase motor 333 
and to propagation of the twist defect towards the dyad. It is possible that 334 
previous nucleosome-Chd1 structures with ADP·BeF3 (Farnung et al., 2017; 335 
Sundaramoorthy et al., 2018) contained the same DNA distortion but that the 336 
lower resolution prevented its observation. Finally, ATP hydrolysis would reset 337 
the remodeller and the enzymatic cycle can resume at the next DNA position. 338 
A major difference between the subfamily I remodeller Chd1 and the 339 
subfamily II remodeller CHD4 is that Chd1 induces unwrapping of the terminal 340 
nucleosomal DNA, whereas CHD4 does not change the DNA trajectory between 341 
SHL -7 to -5. DNA unwrapping is observed for Chd1 in structures and in solution, 342 
and is independent of which ATP or transition state analogue is bound to the 343 
motor domain, indicating it is achieved with the use of binding energy only. Our 344 
observations are consistent with a single-molecule FRET study (Zhong et al., 345 
2019). This major difference in Chd1 and CHD4 molecular function is likely 346 
related to a striking difference in cellular function. Whereas Chd1 functions in 347 
euchromatic regions of the genome during active transcription (Skene et al., 348 
2014), CHD4 plays a central role in the establishment and maintenance of 349 
repressive genome regions. Consistent with these findings, DNA unwrapping 350 
should be prevented in stable heterochromatic regions. It is possible that these 351 
differences in functionality were achieved during evolution by the addition of 352 
distinct auxiliary domains in different CHD subfamilies. 353 
Our structure also maps causative disease mutations and helps to 354 
investigate how these can impair CHD4 function. Our structure suggests that 355 
various mutations may disrupt DNA binding, impede ATP hydrolysis, or uncouple 356 
ATP hydrolysis and DNA translocation. The structure thus suggests the effects of 357 
CHD4 mutations in cancer and intellectual disability syndromes on chromatin 358 
remodelling. It also helps in understanding disease phenotypes of other 359 
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chromatin remodellers such as the BAF complex that shows a related domain 360 
architecture for its ATPase motor. Due to its high resolution, the structure may 361 
also guide drug discovery using chromatin remodellers as targets in the future. 362 
 363 
Methods 364 
Preparation of CHD4 365 
H. sapiens CHD4 (Uniprot Accession code Q14839-1) was amplified from human 366 
cDNA using the following ligation-independent cloning (LIC) compatible primer 367 
pair (Forward primer: 5’-TAC TTC CAA TCC AAT GCA ATG GCG TCG GGC 368 
CTG-3’, reverse primer: 5’-TTA TCC ACT TCC AAT GTT ATT ACT GCT GCT 369 
GGG CTA CCT G-3’). The PCR product containing CHD4 was cloned into a 370 
modified pFastBac vector (a gift from S. Gradia, UC Berkeley, vector 438-C, 371 
Addgene: 55220) via LIC. The CHD4 construct contains a N-terminal 6xHis tag, 372 
followed by a MBP tag, a 10x Asn linker sequence, and a tobacco etch virus 373 
protease cleavage site. All sequences were verified by Sanger sequencing. 374 
The CHD4 plasmid (500 ng) was electroporated into DH10EMBacY cells 375 
(Geneva Biotech) to generate a bacmid encoding full-length H. sapiens CHD4. 376 
Bacmids were subsequently selected and prepared from positive clones using 377 
blue/white selection and isopropanol precipitation. V0 and V1 virus production 378 
was performed as previously described (Farnung et al., 2017). Hi5 cells (600 ml) 379 
grown in ESF-921 media (Expression Systems) were infected with 200 μl of V1 380 
virus for protein expression. The cells were grown for 72 h at 27 °C. Cells were 381 
harvested by centrifugation (238g, 4 °C, 30 min) and resuspended in lysis buffer 382 
(300 mM NaCl, 20 mM Na·HEPES pH 7.4, 10% (v/v) glycerol, 1 mM DTT, 30 mM 383 
imidazole pH 8.0, 0.284 μg ml−l leupeptin, 1.37 μg ml−1 pepstatin A, 0.17 mg ml−1 384 
PMSF, 0.33 mg ml−1 benzamidine). The cell resuspension was frozen and stored 385 
at −80 °C. 386 
 H. sapiens CHD4 was purified at 4 °C. Frozen cell pellets were thawed 387 
and lysed by sonication. Lysates were cleared by two centrifugation steps 388 
(18,000g, 4 °C, 30 min and 235,000g, 4 °C, 60 min). The supernatant containing 389 
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CHD4 was filtered using 0.8-μm syringe filters (Millipore). The filtered sample 390 
was applied onto a GE HisTrap HP 5 ml (GE Healthcare), pre-equilibrated in lysis 391 
buffer. After sample application, the column was washed with 10 CV lysis buffer, 392 
5 CV high salt buffer (1 M NaCl, 20 mM Na·HEPES pH 7.4, 10% (v/v) glycerol, 393 
1 mM DTT, 30 mM imidazole pH 8.0, 0.284 μg ml−1 leupeptin, 1.37 μg ml−1 394 
pepstatin A, 0.17 mg ml−1 PMSF, 0.33 mg ml−1 benzamidine), and 5 CV lysis 395 
buffer. The protein was eluted with a gradient of 0–100% elution buffer (300 mM 396 
NaCl, 20 mM Na·HEPES pH 7.4, 10% (v/v) glycerol, 1 mM DTT, 500 mM 397 
imidazole pH 8.0, 0.284 μg ml−1 leupeptin, 1.37 μg ml−1 pepstatin A, 0.17 mg ml−1 398 
PMSF, 0.33 mg ml−1 benzamidine). Peak fractions were pooled and dialysed for 399 
16 h against 600 ml dialysis buffer (300 mM NaCl, 20 mM Na·HEPES pH 7.4, 400 
10% (v/v) glycerol, 1 mM DTT, 30 mM imidazole) in the presence of 2 mg His6-401 
TEV protease. The dialysed sample was applied to a GE HisTrap HP 5 ml. The 402 
flow-through containing CHD4 was concentrated using an Amicon Millipore 15 ml 403 
50,000 MWCO centrifugal concentrator. The concentrated CHD4 sample was 404 
applied to a GE S200 16/600 pg size exclusion column, pre-equilibrated in gel 405 
filtration buffer (300 mM NaCl, 20 mM Na·HEPES pH 7.4, 10% (v/v) glycerol, 406 
1 mM DTT). Peak fractions were concentrated to ~40 μM, aliquoted, flash frozen, 407 
and stored at −80 °C. Typical yields of H. sapiens CHD4 from 1.2 L of Hi5 insect 408 
cell culture are 2-4 mg. 409 
Preparation of CHD1 410 
S. cerevisiae Chd1 (residues 1-1247) used for FRET assays was cloned, 411 
expressed, and purified similarly to the previously described strategy for full-412 
length Chd1 (Farnung et al., 2017). 413 
Nucleosome preparation 414 
Xenopus laevis histones were expressed and purified as described (Dyer et al., 415 
2003; Farnung et al., 2017). DNA fragments for nucleosome reconstitution were 416 
generated by PCR essentially as described (Farnung et al., 2018). A vector 417 
containing the Widom 601 sequence was used as a template for PCR. Super-418 
helical locations are assigned based on previous publications (Farnung et al., 419 
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2018, 2017; Kujirai et al., 2018; Sundaramoorthy et al., 2018), assuming potential 420 
direction of transcription from negative to positive SHLs. Large-scale PCR 421 
reactions were performed with two PCR primers (Structural studies: forward 422 
primer: TGT TGG ATG TTT TAT AAT TGA GTG GGT TCC TGT TAT TCC TAG 423 
TAA TCA ATC AGT GCC TAT CGA TGT ATA TAT CTG ACA CGT GCC T, 424 
reverse primer: CCC CAT CAG AAT CCC GGT GCC G; FRET assay: forward 425 
primer: /5Cy3/ CAA TCA GTG CCT ATC GAT GTA TAT ATC TGA CAC GTG 426 
CCT, reverse primer: /5Cy5/ CCC CAT CAG AAT CCC GGT GCC G) at a scale 427 
of 25 mL. The DNA construct used for structural studies was designed based on 428 
previously reported constructs used for the study of CHD remodellers.  429 
Nucleosome core particle reconstitution was performed using the salt-gradient 430 
dialysis method (Dyer et al., 2003). Quantification of the reconstituted 431 
nucleosome was achieved by measuring absorbance at 280 nm. Molar extinction 432 
coefficients were determined for protein and nucleic acid components and were 433 
summed to yield a molar extinction coefficient for the reconstituted extended 434 
nucleosome. 435 
Reconstitution of nucleosome-CHD4 complex 436 
Reconstituted nucleosome core particles and CHD4 were mixed at a molar ratio 437 
of 1:2. AMP-PNP was added at a final concentration of 1 mM and the sample 438 
was incubated for 10 minutes on ice. After 10 minutes compensation buffer was 439 
added to a final buffer concentration of 30 mM NaCl, 3 mM MgCl2, 20 mM 440 
NaHEPES pH 7.5, 4 % (v/v) glycerol, 1 mM DTT. The sample was applied to a 441 
Superose 6 Increase 3.2/300 column equilibrated in gel filtration buffer (30 mM 442 
NaCl, 3 mM MgCl2, 20 mM NaHEPES pH 7.5, 5% (v/v) glycerol, 1 mM DTT). 443 
The elution was fractionated in 50 µL fractions and peak fractions were analysed 444 
by SDS-PAGE. Relevant fractions containing nucleosome core particle and 445 
CHD4 were selected and cross-linked with 0.1% (v/v) glutaraldehyde. The 446 
crosslinking reaction was performed for 10 min on ice and subsequently 447 
quenched for 10 min using a final concentration of 2 mM lysine and 8 mM 448 
aspartate. The sample was transferred to a Slide-A-Lyzer MINI Dialysis Unit 449 
20,000 MWCO (Thermo Scientific), and dialysed for 4 h against 600 ml dialysis 450 
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buffer (30 mM NaCl, 3 mM MgCl2, 20 mM NaHEPES pH 7.4, 20 mM TrisHCl pH 451 
7.5, 1 mM DTT). The sample was subsequently concentrated using a Vivaspin 452 
500 ultrafiltration centrifugal concentrator (Sartorius) to a final concentration of 453 
~200-300 µM. 454 
Cryo-EM analysis and image processing 455 
The nucleosome-CHD4 sample was applied to R2/2 gold grids (Quantifoil). The 456 
grids were glow-discharged for 100 s before sample application of 2 l on each 457 
side of the grid. The sample was subsequently blotted for 8.5 s (Blot force 5) and 458 
vitrified by plunging into liquid ethane with a Vitrobot Mark IV (FEI Company) 459 
operated at 4 °C and 100 % humidity. Cryo-EM data were acquired on a Titan 460 
Krios transmission electron microscope (FEI/Thermo) operated at 300 keV, 461 
equipped with a K2 summit direct detector (Gatan) and a GIF Quantum energy 462 
filter. Automated data acquisition was carried out using FEI EPU software at a 463 
nominal magnification of 130,000 in nanoprobe EF-TEM mode. Image stacks of 464 
40 frames were collected in counting mode over 10 s. The dose rate was ~4.3-465 
4.5 e per Å 2 per s for a total dose of ~43-45 e Å 2. A total of 3,904 image stacks 466 
were collected. 467 
Micrograph frames were stacked and processed. All micrographs were 468 
CTF and motion corrected using Warp (Tegunov and Cramer, 2018). Particles 469 
were picked using an in-house trained instance of the neural network BoxNet2 of 470 
Warp, yielding 650,598 particle positions. Particles were extracted with a box size 471 
of 3002 pixel and normalized. Image processing was performed with RELION 3.0-472 
beta 2 (Zivanov et al., 2018). Using a 30 Å  low-pass filtered ab initio model 473 
generated in cryoSPARC from 1,679 particles (Figure 1-figure supplement 2c) we 474 
performed one round of 3D classification of all particle images with image 475 
alignment. One class with defined density for the nucleosome-CHD4 complex 476 
was selected for a second round of classification. The second round of 477 
classification resulted in two classes with one copy of CHD4 bound to the 478 
nucleosome. The respective classes were selected and 3D refined. The refined 479 
nucleosome-CHD4 model was subsequently CTF refined and the beam tilt was 480 
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estimated based on grouping of beam tilt classes according to their exposure 481 
positions. The CTF refined particles were submitted to one additional round of 482 
masked 3D classification without image alignment. The mask encompassed 483 
CHD4. The most occupied class from this classification was subsequently CTF-484 
refined. The final particle reconstruction was obtained from a 3D refinement with 485 
a mask that encompasses the entire nucleosome-CHD4 complex. 486 
The nucleosome-CHD4 reconstruction was obtained from 89,623 particles 487 
with an overall resolution of 3.1 Å  (gold-standard Fourier shell correlation 0.143 488 
criterion). The final map was sharpened with a B-factor of 36 Å 2. To exclude 489 
that the reconstruction could be a mixture of particles with CHD4 bound to either 490 
SHL –2 or SHL +2, CHD4 signal was subtracted and prior angular and 491 
translational information for every particle was removed. The subtracted particles 492 
were then refined against a synthetic nucleosome core particle map lacking 493 
CHD4. As expected, the refinement resulted in a reconstruction where only 494 
density for the nucleosome core particle was observed. Subsequently, the 495 
particle subtraction was reverted and a 3D classification without image alignment 496 
against a single class was performed. This 3D classification employed the 497 
angular and translational information provided from the subtraction refinement. 498 
The resulting reconstruction showed clear density for CHD4 only at SHL +2, and 499 
not at SHL -2, giving a clear indication that the final nucleosome-CHD4 500 
reconstruction contains CHD4 bound only at SHL +2 (Figure 1-figure supplement 501 
4f). We cannot rule out, however, that our map is still to some extent a mix of 502 
CHD4 bound on either side of the nucleosome. 503 
 The second round of 3D classification yielded a class with a nucleosome-504 
CHD42 complex. The particles were subsequently classified and refined. The 505 
resulting reconstruction with 40,233 particles had an overall resolution of 4.0 Å  506 
(gold-standard Fourier shell correlation 0.143 criterion). The final map was 507 
sharpened with a B-factor of 86 Å 2. Local resolution estimates for both 508 
structures were determined using the built-in RELION tool.  509 
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Model building 510 
Crystal structures of the X. laevis nucleosome with the Widom 601 sequence 511 
(Vasudevan et al., 2010) (PDB code 3LZ0) and the double chromodomain of 512 
CHD4 (PDB code 4O9I) were placed into the density of the nucleosome-CHD4 513 
complex as rigid bodies using UCSF Chimera. The protein sequence of the 514 
ATPase motor of CHD4 (residues 706-1196) was ‘one-to-one threaded’ using the 515 
ATPase motor of S. cerevisiae Chd1 (PDB code 5O9G) as a template by 516 
employing Phyre2 (Kelley et al., 2015). The threaded model was placed into the 517 
density as a rigid body using UCSF Chimera (Goddard et al., 2018). Additional 518 
density belonging to helical extensions and loops present in the ATPase motor 519 
region were modelled de novo. The modelled sequence range 1405-1416 is 520 
assigned tentatively based on a previously published Chd1 crystal structure (PDB 521 
code 3MWY). 522 
The nucleosome structure, double chromodomain structure, and ATPase 523 
motor model were adjusted manually in COOT (version 0.9-pre) (Emsley et al., 524 
2010). The structure of PHD finger 2 (Mansfield et al., 2011) was then manually 525 
placed into the remaining, weaker density next to the double chromodomain and 526 
rigid-body docked (Figure 1-figure supplement 3), assisted by PDB code 6Q3M. 527 
Additional structural elements such as the H4 tail, the C-terminal bridge and loop 528 
regions of CHD4 were built using COOT. AMP-PNP and a coordinated Mg2+ ion 529 
were placed into the corresponding density. AMP-PNP was derived from the 530 
monomer library in COOT. The high resolution of our reconstruction enabled us 531 
to model several DNA-interacting side chains in two alternative conformations. 532 
The complete model was real-space refined in PHENIX (Afonine et al., 2018) 533 
with global minimization, local rotamer fitting, morphing, and simulated annealing. 534 
To model the nucleosome-CHD42 complex, the CHD4 model was duplicated and 535 
the second copy was rigid body docked into the additional density using UCSF 536 
ChimeraX (Goddard et al., 2018). The resulting structure was real space refined 537 
in PHENIX with global minimization, local rotamer fitting, morphing, and 538 
simulated annealing. 539 
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Förster resonance energy transfer (FRET) assay 540 
100 nM of NCP with Cy3 and Cy5 5’-terminal DNA ends was incubated with 541 
300 nM S. cerevisiae Chd1 (residues 1-1247) or full-length CHD4 and 1 mM 542 
ADP·BeF3 or 1 mM AMP-PNP at final reaction conditions of 50 mM NaCl, 3 mM 543 
MgCl2, 20 mM NaHEPES pH 7.4, 0.1 mg/mL BSA, 10 % (v/v) glycerol, 1 mM 544 
DTT. To increase FRET efficiency, we used a DNA construct that is shortened by 545 
18 bp on the DNA exit side compared to the construct used for the structural 546 
studies. The sample was subsequently incubated for 30 minutes and transferred 547 
to 384-well plates. The reaction was then monitored using a fluorescence 548 
emission scan from 520-740 nm in a Tecan infinite m1000 pro plate reader with 549 
an excitation wavelength of 510 nm. All reactions were performed in triplicates in 550 
independent experiments. Emission spectra were normalized by total emissions. 551 
Averages of the triplicates and corresponding standard deviations are reported. 552 
The results were plotted using Matplotlib. 553 
Figure generation 554 
Figures were generated using PyMol (version 2.2.2) and UCSF ChimeraX. 555 
 556 
Data availability 557 
The cryo-EM reconstructions and final models were deposited with the Electron 558 
Microscopy Data Base (accession codes EMD-10058 and EMD-10059) and with 559 
the Protein Data Bank (accession code 6RYR and 6RYU). The raw image data 560 
and corresponding WARP sessions have been deposited to EMPIAR (EMPIAR-561 
10411). 562 
Figure legends 563 
Figure 1 | Structure of the nucleosome-CHD4 complex. a, Schematic of 564 
domain architecture of CHD4. Domain borders are indicated. b-d, Cartoon model 565 
viewed from the top (b), dyad (c), and side (d). Histones H2A, H2B, H3, H4, 566 
tracking strand, guide strand, CHD4 PHD finger 2, double chromodomain, 567 
ATPase lobe 1, and ATPase lobe 2 are coloured in yellow, red, light blue, green, 568 
blue, cyan, pink, purple, orange, and forest green, respectively. Colour code used 569 
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throughout. The dyad axis is indicated as a black line or a black oval circle. 570 
Magnesium and zinc ions shown as pink and grey spheres, respectively. AMP-571 
PNP shown in stick representation. 572 
Figure 2 | Comparison with nucleosome-Chd1 structure. a, CHD4 (left) does 573 
not possess a DNA-binding region and does not detach DNA from the second 574 
gyre. Chd1 (right) detaches DNA from SHL -7 to -5, stabilizes the detached DNA 575 
via its DNA binding region, and introduces a ~60° bend with respect to the 576 
canonical DNA position observed in the nucleosome-CHD4 structure. b, 577 
Schematic of experimental FRET setup. c, Fluorescence emission spectra 578 
produced after excitation at 510 nm of Cy3/Cy5 labelled nucleosome in the 579 
presence of S. cerevisiae Chd1 (residues 1-1247) or H. sapiens CHD4 and AMP-580 
PNP or ADP·BeF3 show unwrapping of nucleosomal DNA by Chd1 but not by 581 
CHD4. 582 
Figure 3 | CHD4-DNA interactions and DNA distortion. a, CHD4 interacts 583 
extensively with nucleosomal DNA around SHL +2. ATPase lobe 1 and lobe 2 of 584 
CHD4 are shown. Guide and tracking strands are indicated. ATPase motifs are 585 
shown as coloured spheres and labelled. b, Schematic depiction of DNA 586 
interactions of the double chromodomain, ATPase lobe 1 and lobe 2. c, Asn1010, 587 
Trp1148 and Arg1227 insert into the minor groove between DNA tracking and 588 
guide strand. The two conformations of the Arg1127 side chain are shown. 589 
Nucleic acids are shown as cartoons with their respective surfaces. d, Detailed 590 
cartoon representation of DNA distortion at SHL +2. Canonical nucleosome (PDB 591 
code 3LZ0, grey), AMP-PNP bound NCP-CHD4 structure (this study, blue and 592 
cyan), and ADP bound nucleosome-Snf2 structure (PDB code 5Z3O, red and 593 
yellow) are shown. Phosphate atoms shown as spheres. 594 
Figure 4 | CHD4 contacts H3 and H4. a, ATPase lobe 2 interacts extensively 595 
with the H4 tail. b, A loop in ATPase lobe 2 contacts H3 alpha helix 1 and 596 
neighbouring residues. c, The double chromodomain of CHD4 contacts the H3 597 
N-terminal tail. H3 core is shown in blue, H3 tail density from the low-pass filtered 598 
final map (7 Å) in teal, and the double chromodomain in purple. 599 
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Figure 5 | The nucleosome can bind two copies of CHD4. Cartoon model of 600 
the nucleosome-CHD42 structure viewed from the top (a), and dyad view (b). 601 
Figure 6 | CHD4 mutations in cancer and Sifrim-Hitz-Weiss syndrome. 602 
Missense mutations that occur in endometrial cancer (blue spheres) and Sifrim-603 
Hitz-Weiss syndrome (yellow spheres) mapped onto the CHD4 structure. 604 
Residue numbering is indicated. Nucleosomal DNA at SHL +2 is shown in a 605 
semi-transparent cartoon representation. 606 
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Figure supplements 902 
Figure 1-figure supplement 1 | Formation of the nucleosome-CHD4 903 
complex. 904 
a, Schematic of DNA construct to form nucleosome-CHD4 complex. 905 
Extranucleosomal DNA length, entry, and exit sides are indicated. b, Formation 906 
of the nucleosome-CHD4 complex on a Superose 6 Increase 3.2/30 size 907 
exclusion chromatography column. Red and blue curve shows absorption at 260 908 
nm and 280 nm milli absorption units, respectively. c, SDS-PAGE gel with peak 909 
fraction containing the formed nucleosome-CHD4 complex. 910 
Figure 1-figure supplement 2 | Cryo-EM structure determination. 911 
a, Representative micrograph of data collection. The micrograph was denoised 912 
using Warp(Tegunov and Cramer, 2018). Scale bar with a length of 500 Å is 913 
shown. b, 2D classes of single copy CHD4 bound to a nucleosome. Scale bar 914 
with a length of 200 Å is shown. c, Classification tree employed to obtain cryo-915 
EM density of CHD4 bound to a nucleosome. Particle numbers and class 916 
distribution percentages are indicated. Final reconstructions are highlighted. 917 
Figure 1-figure supplement 3 | Cryo-EM densities. 918 
a, Cartoon model of CHD4-nucleosome structure with corresponding post-919 
processed Coulomb potential map shown in silver. b, Nucleosomal DNA with 920 
Coulomb potential map. c, Histone octamer with Coulomb potential map d, 921 
Cartoon model of two copies of CHD4 engaged with the nucleosome and 922 
corresponding Coulomb potential map. e, Representative density of histone 923 
residues. f, Representative density of CHD4 residues. g, Coulomb potential map 924 
of density near DNA at SHL +2. h, DNA density around dyad axis with fitted DNA 925 
model. Base identities used to fit register and directionality are indicated on the 926 
left. N, R, and Y indicate any nucleotide, purine, or pyrimidine, respectively. 927 
Matching sequence provided on the right. i, Active site density with fitted AMP-928 
PNP and coordinated Mg2+ ion. j, Density of C-terminal bridge helix. k, Cartoon 929 
model of PHD finger 2 with corresponding local resolution filtered Coulomb 930 
potential map. 931 
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Figure 1-figure supplement 4 | Data quality and metrics. a, FSC curves. b-c,  932 
Angular distribution plots. d-e, Local resolution of CHD4 structures. Densities are 933 
coloured according to resolution as indicated. f, Procedure employed to test for 934 
mixture of CHD4 bound at SHL +2 and SHL -2. Density was only observed on 935 
one site of the NCP, indicating that CHD4 binds the NCP only at SHL +2. 936 
Figure 2-source data 1 | FRET source data. Average and standard deviation 937 
data for Figure 2f. 938 
Figure 3-figure supplement 1 | Comparison of CHD4 with Chd1 and other 939 
chromatin remodellers. Sequence alignment of ATPase regions in H. sapiens 940 
CHD4 (706-1230), CHD5 (680-1204), CHD3 (716-1240), CHD1 (460-980), CHD2 941 
(464-983), S. cerevisiae Chd1 (358-880), S. cerevisiae Isw1 (181-686), S. 942 
cerevisiae Snf2 (742-1268), H. sapiens CHD6 (443-967), CHD7 (950-1475), 943 
CHD9 (842-1367), and CHD8 (793-1318). Important elements and ATPase 944 
motifs are indicated. Sequence coloured according to identity. Dark and light 945 
shades of blue indicate high and low conservation, respectively. Alignment 946 
generated with MAFFT (Katoh and Standley, 2013) and visualized using JalView 947 
(Waterhouse et al., 2009). 948 
 949 
Table 1 | Cryo-EM data collection, refinement and validation statistics 950 
Table 2 | CHD4 mutations in cancer and Sifrim-Hitz-Weiss syndrome 951 
 952 
Video 1 | Cryo-EM density and structure of the nucleosome-CHD4 complex 953 
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Data collection and 
processing 
    
Magnification  130,000 130,000   
Voltage (kV) 300 300   
Electron exposure (e–/Å
2
) 43-45 43-45   
Defocus range (μm) 0.25-4 0.25-4   
Pixel size (Å) 1.05 1.05   
Symmetry imposed C1 C1   
Initial particle images (no.) 650,599 650,599   
Final particle images (no.) 89,623 40,233   
Map resolution (Å) 









Map resolution range (Å) 3.0-5 3.7-8.3   
     
Refinement     






Map sharpening B factor (Å
2
) -36 -86 
Model composition 
    Non-hydrogen atoms 
    Protein residues 
    Nucleotides 















    Protein 
    Nucleotide 











    Bond lengths (Å)  









    MolProbity score  
    Clashscore   










 Ramachandran plot 
    Favored (%) 
    Allowed (%)  

















Table 2 | CHD4 mutations in cancer and Sifrim-Hitz-Weiss syndrome 968 




Location Predicted effect 
based on structure 
Biochemical 
observations 
Cancer     
   Cys464Tyr PHD finger 2 Disruption of Zn
2+ 
binding in PHD finger 2 
Reduction in ATPase 
activity (Kovač et al., 
2018) 
 Val558Phe Double 
chromodomain 
 Reduced ATPase 
activity (Kovač et al., 
2018) 
 Arg572Gln Double 
chromodomain 
Disruption of contact 
with tracking strand 
Reduced DNA 
binding affinity, Loss 
of full remodelling 
activity and ATPase 
activity(Kovač et al., 
2018) 
 Leu912Val ATPase lobe 2 No prediction made Reduction of ATPase 
activity (Kovač et al., 
2018) 
 His1151Arg ATPase lobe 2 In close proximity to 
motif Va, might disrupt 
contact of Trp1148 
Reduction of ATPase 
activity, abolishment 
of remodelling activity 
(Kovač et al., 2018) 
 Arg1162Gln ATPase lobe 
2, motif VI 
Located in ATPase 
motif VI (arginine 
finger), Disruption of 
interaction with ATP 
Reduction of ATPase 
activity (Kovač et al., 
2018) 
     His1196Tyr ATPase lobe 2 Located in the C-
terminal bridge region, 
Removes negative 
regulation 
Speed of chromatin 
remodelling is 
increased and better 
nucleosome centering 
capability (Kovač et 
al., 2018) 
 Leu1215 ATPase 
lobe2/C-
terminal bridge 






(Sifrim et al., 
2016; Weiss et 
al., 2016) 
    
 Cys467Tyr PHD finger 2 Disruption of Zn
2+ 
binding in PHD finger 2 
 
 Ser851Tyr ATPase lobe 1   
 Gly1003Asp 
 
ATPase lobe 2 Disruption of contact 
with H3 
 
 Arg1068His ATPase lobe 2 Disruption of structural 




ATPase lobe 2 Disruption of contact 
with DNA minor 
groove, equivalent 
arginine residue in 
SMARCA4 is 
implicated in “Coffin 
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Siris syndrome” 
 Trp1148Leu ATPase lobe 
2, motif Va 
Disruption of contact 
with guide strand 
Uncoupling of 
ATPase activity and 
chromatin 
remodelling (Liu et 
al., 2017) 
 Arg1173Leu  Destabilization  





Residues modelled in structure
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NCP with 145 bp
























3D classification with ab initio model
197,979 particles, 3.6 Å
NCP-CHD4 complex 1
89,623 particles
3.1 Å, B-factor = -36 Å2
























NCP with double CHD4
15 %, 67,981 particles
NCP with single CHD4
3D classification
Masked 3D classification on CHD4 without image alignment











Global 3D classification & refinement
NCP-CHD4 complex 2
40,233 particles









































































































































Nucleosome-CHD4 (Fourier shell correlation masked map)
Nucleosome-CHD42 (Fourier shell correlation corrected)
Nucleosome-CHD42 (Fourier shell correlation masked map)
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S S E F A KWA P T L R T I S F K G S P N E R K A K Q - - - - - - - - - - - - - - - - - - - - A K I R A G E F D V V L T T F E Y I I K E R A L L S K V K WV H M I I D E G H R M K N A Q S
E R E F R T WT - E MN A I V Y H G S Q I S R QM I QQ Y E M V Y R D A QG - - - - - - - - N P L S G V F K F H V V I T T F E M I L A D C P E L K K I H WS C V I I D E A H R L K N R N C
E R E F R T WT - E L N V V V Y H G S Q A S R R T I Q L Y E M Y F K D P QG - - - - - - - - R V I K G S Y K F H A I I T T F E M I L T D C P E L R N I P WR C V V I D E A H R L K N R N C
E R E F R T WT - D I N V V V Y H G S L I S R QM I QQ Y E M Y F R D S QG - - - - - - - - R I I R G A Y R F Q A I I T T F E M I L G G C G E L N A I E WR C V I I D E A H R L K N K N C





































K F F R V L N - G Y S L QH K L L L T G T P L QN N L E E L F H L L N F L T P E R F H N L E G F L E - - - - - - - - - - - - - - - E F A D I A K E D Q I K K L H DM L G P H M L R R L K A
K F F R V L N - S Y K I D Y K L L L T G T P L QN N L E E L F H L L N F L T P E R F N N L E G F L E - - - - - - - - - - - - - - - E F A D I S K E D Q I K K L H D L L G P H M L R R L K A
K F F R V L N - G Y K I D H K L L L T G T P L QN N L E E L F H L L N F L T P E R F N N L E G F L E - - - - - - - - - - - - - - - E F A D I S K E D Q I K K L H D L L G P H M L R R L K A
L L Y K T L I - D F K S N H R L L I T G T P L QN S L K E L WS L L H F I M P E K F S S WE D F E E - - - - - - - - - - - - - - - E H G K - G R E Y G Y A S L H K E L E P F L L R R V K K
L L Y K T L I - D F K S N H R L L I T G T P L QN S L K E L WS L L H F I M P E K F E F WE D F E E - - - - - - - - - - - - - - - D H G K - G R E N G Y Q S L H K V L E P F L L R R V K K
S L Y E S L N - S F K V A N R M L I T G T P L QN N I K E L A A L V N F L M P G R F T I D Q E I D F - - - - - - - - - - - - - - - E N QD E E Q E E Y I H D L H R R I Q P F I L R R L K K
M L S Q V L R - E F T S R N R L L I T G T P L QN N L H E L WA L L N F L L P D I F S D A QD F D DWF S S - - - - - - - - - - - E S T E E D QD K I V K Q L H T V L Q P F L L R R I K S
K L S L T L N T H Y H A D Y R L I L T G T P L QN N L P E L WA L L N F V L P K I F N S V K S F D E WF N T P F A N T G G QD K I E L S E E E T L L V I R R L H K V L R P F L L R R L K K
K L L E G L K - L MA L E H K V L L T G T P L QN S V E E L F S L L N F L E P S Q F P S E T A F L E - - - - - - - - - - - - - - - E F G D L K T E E Q V K K L Q S I L K P MM L R R L K D
K L L E G L K - MMD L E H K V L L T G T P L QN T V E E L F S L L H F L E P S R F P S E T T F MQ - - - - - - - - - - - - - - - E F G D L K T E E Q V Q K L Q A I L K P MM L R R L K E
K L L E G L K - L MN L E H K V L L T G T P L QN T V E E L F S L L H F L E P L R F P S E S T F MQ - - - - - - - - - - - - - - - E F G D L K T E E Q V Q K L Q A I L K P MM L R R L K E





































D V F K N M P S K T E L I V R V E L S P MQ K K Y Y K Y I L T R N F E A L N A R G G G N Q V - - - S L L N V VMD L K K C C N H P Y L F P V A A M E A - - - - - - - - - P K M P N G M Y D
D V F K N M P A K T E L I V R V E L S QMQ K K Y Y K F I L T R N F E A L N S K G G G N Q V - - - S L L N I MMD L K K C C N H P Y L F P V A A V E A - - - - - - - - - P V L P N G S Y D
D V F K N M P A K T E L I V R V E L S P MQ K K Y Y K Y I L T R N F E A L N S R G G G N Q V - - - S L L N I MMD L K K C C N H P Y L F P V A A M E S - - - - - - - - - P K L P S G A Y E
D V E K S L P A K V E Q I L R M E M S A L Q K Q Y Y KW I L T R N Y K A L S K G S K G S T S - - - G F L N I MM E L K K C C N H C Y L I K - - P P D N - - - - - - - - - N E F Y N K Q E A
D V E K S L P A K V E Q I L R V E M S A L Q K Q Y Y KW I L T R N Y K A L A K G T R G S T S - - - G F L N I VM E L K K C C N H C Y L I K - - P P E E - - - - - - - - - N E R E N G Q E I
D V E K S L P S K T E R I L R V E L S D V Q T E Y Y K N I L T K N Y S A L T A G A K G G H F - - - S L L N I MN E L K K A S N H P Y L F D - - N A E E R V L Q K F G - - D G K M T R E N V
D V E T S L L P K K E L N L Y V G M S S MQ K KWY K K I L E K D L D A V N G S N G S K E S K - T R L L N I MMQ L R K C C N H P Y L F D - - G A E P - - - - - - - - - G P P Y T T D E -
D V E K E L P D K V E K V V K C K M S A L QQ I M Y QQM L K Y R R L F I G D QN N K K M V G L R G F N N Q I MQ L K K I C N H P F V F E - - E V E D Q I - - - - - - - N P T R E T N D -
D V E K N L A P K Q E T I I E V E L T N I Q K K Y Y R A I L E K N F S F L T K G A N QH N M - - P N L I N T MM E L R K C C N H P Y L I N - - G A E E K I L E D F R K T H S P D A P D F Q
D V E K N L A P K E E T I I E V E L T N I Q K K Y Y R A I L E K N F T F L S K G G G QA N V - - P N L L N T MM E L R K C C N H P Y L I N - - G A E E K I L E E F K E T H N A E S P D F Q
D V E K K L A P K E E T I I E V E L T N I Q K K Y Y R A I L E K N F S F L S K G A G Q T N V - - P N L V N T MM E L R K C C N H P Y L I K - - G A E E K I L G E F R D T Y N P A A S D F H





































G S A L I R A S G K L L L L Q K M L K N L K E G G H R V L I F S QM T K M L D L L E D F L E H E G Y K Y E R I D G G I T G N M R Q E A I D R F N A P G A QQ F C F L L S T R A G G L G I N
G S S L V K S S G K L M L L Q K M L K K L R D E G H R V L I F S QM T K M L D L L E D F L E Y E G Y K Y E R I D G G I T G G L R Q E A I D R F N A P G A QQ F C F L L S T R A G G L G I N
G G A L I K S S G K L M L L Q K M L R K L K E QG H R V L I F S QM T K M L D L L E D F L D Y E G Y K Y E R I D G G I T G A L R Q E A I D R F N A P G A QQ F C F L L S T R A G G L G I N
L QH L I R S S G K L I L L D K L L I R L R E R G N R V L I F S QM V R M L D I L A E Y L K Y R Q F P F Q R L D G S I K G E L R K Q A L D H F N A E G S E D F C F L L S T R A G G L G I N
L L S L I R S S G K L I L L D K L L T R L R E R G N R V L I F S QM V R M L D I L A E Y L T I K H Y P F Q R L D G S I K G E I R K Q A L D H F N A D G S E D F C F L L S T R A G G L G I N
L R G L I M S S G K M V L L D Q L L T R L K K D G H R V L I F S QM V R M L D I L G D Y L S I K G I N F Q R L D G T V P S A Q R R I S I D H F N S P D S N D F V F L L S T R A G G L G I N
- - H L V Y N A A K L Q V L D K L L K K L K E E G S R V L I F S QM S R L L D I L E D Y C Y F R N Y E Y C R I D G S T A H E D R I Q A I D D Y N A P D S K K F V F L L T T R A G G L G I N
- - D I WR V A G K F E L L D R I L P K L K A T G H R V L I F F QM T Q I MD I M E D F L R Y I N I K Y L R L D G H T K S D E R S E L L R L F N A P D S E Y L C F I L S T R A G G L G L N
L Q A M I Q A A G K L V L I D K L L P K L I A G G H K V L I F S QM V R C L D I L E D Y L I Q R R Y T Y E R I D G R V R G N L R Q A A I D R F C K P D S D R F V F L L C T R A G G L G I N
L Q A M I Q A A G K L V L I D K L L P K L K A G G H R V L I F S QM V R C L D I L E D Y L I Q R R Y P Y E R I D G R V R G N L R Q A A I D R F S K P D S D R F V F L L C T R A G G L G I N
L Q A M I Q S A G K L V L I D K L L P K M K A G G H K V L I F S QM V R C L D I L E D Y L I H K R Y L Y E R I D G R V R G N L R Q A A I D R F S K P D S D R F V F L L C T R A G G L G I N





































L A T A D T V I I Y D S DWN P H N D I Q A F S R A H R I G QN K K VM I Y R F V T R A S V E E R I T Q V A K K K MM L T H L V V R P G L G - - - - - - - - - - - - S K T G S M S K Q E L
L A T A D T V I I Y D S DWN P H N D I Q A F S R A H R I G QN K K VM I Y R F V T R A S V E E R I T Q V A K R K MM L T H L V V R P G L G - - - - - - - - - - - - S K S G S M T K Q E L
L A T A D T V I I F D S DWN P H N D I Q A F S R A H R I G Q A N K VM I Y R F V T R A S V E E R I T Q V A K R K MM L T H L V V R P G L G - - - - - - - - - - - - S K A G S M S K Q E L
L A S A D T V V I F D S DWN P QN D L Q A QA R A H R I G Q K K Q V N I Y R L V T K G S V E E D I L E R A K K K M V L D H L V I Q R MD T T G K T V L H T G S A P S S S T P F N K E E L
L A S A D T V V I F D S DWN P QN D L Q A QA R A H R I G Q K K Q V N I Y R L V T K G T V E E E I I E R A K K K M V L D H L V I Q R MD T T G R T I L E N N S G R S N S N P F N K E E L
L M T A D T V V I F D S DWN P QA D L Q A MA R A H R I G Q K N H VM V Y R L V S K D T V E E E V L E R A R K K M I L E Y A I I S L G V T D G N K Y - - - - - - - T K K N E P N A G E L
L T S A D V V V L Y D S DWN P QA D L Q A MD R A H R I G Q K K Q V K V F R L V T D N S V E E K I L E R A T Q K L R L D Q L V I Q QN R T S L K K - - - - - - - - K E N K A D S K D A L
L Q T A D T V I I F D T DWN P H QD L QA QD R A H R I G Q K N E V R I L R L I T T N S V E E V I L E R A Y K K L D I D G K V I Q A G K F D - - - - - - - - - - - N K S T S E E Q E A L
L T A A D T C I I F D S DWN P QN D L Q A QA R C H R I G Q S K A V K V Y R L I T R N S Y E R E M F D K A S L K L G L D K A V L QD I N - R K G G T - - - - - - - N G V QQ L S K M E V
L T A A D T C I I F D S DWN P QN D L Q A QA R C H R I G Q S K S V K I Y R L I T R N S Y E R E M F D K A S L K L G L D K A V L Q S M S G R E N A T - - - - - - - N G V QQ L S K K E I
L T A A D T C I I F D S DWN P QN D L Q A QA R C H R I G QN K A V K V Y R L V T R N S Y E R E M F D R A S L K L G L D K A V L Q S M S G R E S N V - - - - - - - G G I Q Q L S K K E I





































D D I L K F G T E E L F K D E
D D I L K F G T E E L F K D D
D D I L K F G T E E L F K D E
S A I L K F G A E E L F K E P
T A I L K F G A E D L F K E L
S A I L K F G A G N M F T A T
L S M I Q H G A A D V F K S G
L R S L L D A E E E R R K K R
E D L L R K G A Y G A L MD E
E D L L R K G A Y G A L MD E
E D L L R R G A Y G A I M E E






I (Walker A, P-loop) Ia
IcLoop (residues 832-837) II (Walker B + IIa)
